Comprehensive characterization of the attenuated double auxotroph mycobacterium tuberculosisΔleuDΔpanCD as an alternative to H37Rv by Mouton, Jomien M. et al.
fmicb-10-01922 August 17, 2019 Time: 15:44 # 1
ORIGINAL RESEARCH
published: 20 August 2019
doi: 10.3389/fmicb.2019.01922
Edited by:
Mattias Collin,
Lund University, Sweden
Reviewed by:
Fabiana Bigi,
National Institute of Agricultural
Technology, Argentina
Mario Alberto Flores-Valdez,
CONACYT Centro de Investigación y
Asistencia en Tecnología y Diseño del
Estado de Jalisco (CIATEJ), Mexico
*Correspondence:
Samantha L. Sampson
ssampson@sun.ac.za
Specialty section:
This article was submitted to
Infectious Diseases,
a section of the journal
Frontiers in Microbiology
Received: 15 May 2019
Accepted: 05 August 2019
Published: 20 August 2019
Citation:
Mouton JM, Heunis T,
Dippenaar A, Gallant JL, Kleynhans L
and Sampson SL (2019)
Comprehensive Characterization
of the Attenuated Double Auxotroph
Mycobacterium
tuberculosis1leuD1panCD as an
Alternative to H37Rv.
Front. Microbiol. 10:1922.
doi: 10.3389/fmicb.2019.01922
Comprehensive Characterization of
the Attenuated Double Auxotroph
Mycobacterium
tuberculosis1leuD1panCD as an
Alternative to H37Rv
Jomien M. Mouton1, Tiaan Heunis1,2, Anzaan Dippenaar1, James L. Gallant1,3,
Léanie Kleynhans1 and Samantha L. Sampson1*
1 Department of Science and Technology/National Research Foundation (DST/NRF) Centre of Excellence for Biomedical
Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular
Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa,
2 Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, United Kingdom, 3 Section
of Molecular Microbiology, Amsterdam Institute of Molecules, Medicines, and Systems, Vrije Universiteit Amsterdam,
Amsterdam, Netherlands
Although currently available model organisms such as Mycobacterium smegmatis and
Mycobacterium bovis Bacillus Calmette-Guérin (BCG) have significantly contributed to
our understanding of tuberculosis (TB) biology, these models have limitations such
as differences in genome size, growth rates and virulence. However, attenuated
Mycobacterium tuberculosis strains may provide more representative, safer models
to study M. tuberculosis biology. For example, the M. tuberculosis 1leuD1panCD
double auxotroph, has undergone rigorous in vitro and in vivo safety testing. Like
other auxotrophic strains, this has subsequently been approved for use in biosafety
level (BSL) 2 facilities. Auxotrophic strains have been assessed as models for drug-
resistant M. tuberculosis and for studying latent TB. These offer the potential as safe
and useful models, but it is important to understand how well these recapitulate salient
features of non-attenuated M. tuberculosis. We therefore performed a comprehensive
comparison of M. tuberculosis H37Rv and M. tuberculosis1leuD1panCD. These
strains demonstrated similar in vitro and intra-macrophage replication rates, similar
responses to anti-TB agents and whole genome sequence conservation. Shotgun
proteomics analysis suggested that M. tuberculosis1leuD1panCD has a heightened
stress response that leads to reduced bacterial replication during exposure to
acid stress, which has been verified using a dual-fluorescent replication reporter
assay. Importantly, infection of human peripheral blood mononuclear cells with the
2 strains elicited comparable cytokine production, demonstrating the suitability of
M. tuberculosis1leuD1panCD for immunological assays. We provide comprehensive
evidence to support the judicious use of M. tuberculosis1leuD1panCD as a safe
and suitable model organism for M. tuberculosis research, without the need for a
BSL3 facility.
Keywords: Mycobacterium tuberculosis, biosafety level 2, attenuated auxotroph, model organism, H37Rv
Frontiers in Microbiology | www.frontiersin.org 1 August 2019 | Volume 10 | Article 1922
fmicb-10-01922 August 17, 2019 Time: 15:44 # 2
Mouton et al. An Alternative Model for Tuberculosis Research
INTRODUCTION
In order to radically reduce TB deaths and incidence by 2030,
as set out by the End TB Strategy (World Health Organisation
[WHO], 2018a), there is a need for improved TB therapies
and more effective ways of studying the deadly pathogen
Mycobacterium tuberculosis. Current research challenges include
restricted access to Biosafety level 3 (BSL3) facilities and
the slow growth of M. tuberculosis. This emphasizes the
need for mycobacterial model systems that can facilitate our
understanding of M. tuberculosis pathogenesis. Despite studies
showing the use of currently available model organisms such
as Mycobacterium smegmatis and Mycobacterium bovis Bacillus
Calmette-Guérin (BCG) to have significantly contributed to the
understanding of M. tuberculosis, these models have limitations.
Apart from being non-pathogenic, M. smegmatis is also
substantially different from M. tuberculosis in terms of its larger
genome size and considerably shorter doubling time (Gill et al.,
2009; Mouton et al., 2016). The model organism BCG is known to
contain a natural RD1 deletion (Behr et al., 1999), which encodes
the known virulence factors early secreted antigenic target-6 kDa
(ESAT-6) (Harboe et al., 1996) and culture filtrate protein-10 kDa
(CFP-10) (Lewis et al., 2003; Gao et al., 2004; Guinn et al.,
2004; Fortune et al., 2005), suggesting that the immune response
elicited by BCG will be altered in comparison to M. tuberculosis.
Several attenuated strains of M. tuberculosis have been
developed (Hondalus et al., 2000; Sambandamurthy et al.,
2002, 2005; Sampson et al., 2004, 2011; Derrick et al., 2007;
Clemmensen et al., 2017; Kar et al., 2017; Bahal et al., 2018)
that have the potential to serve as model organisms to study
M. tuberculosis biology. These include strains with a deletion
in the bioA gene, disrupting biotin synthesis (Kar et al., 2017)
or single mutation in the eccCa1 gene, disrupting ESX-1 type
VII secretion, resulting in reduced host immune responses and
immunopathology (Clemmensen et al., 2017). To improve safety,
several M. tuberculosis strains with two or more attenuating
mutations have been developed. These include 1RD11panCD
(Sambandamurthy et al., 2002, 2005), which similarly to BCG
does not include the RD1 region. Doubly auxotrophic strains
include1lysA1panCD (Sambandamurthy et al., 2002, 2005) and
1leuD1panCD (Sampson et al., 2004). Recent work generated
a drug-susceptible and drug-resistant triple auxotrophic stain
of M. tuberculosis, which provides a safe model for studying
drug-resistant M. tuberculosis under BSL2 conditions (Vilchèze
et al., 2018). Another interesting development is the use of a
streptomycin-dependent M. tuberculosis strain (M. tuberculosis
18b) as a model of latent TB (Zhang et al., 2012). These strains
offer potential as research models, but need comprehensive
characterization to assess their suitability to the research
question at hand.
The severely attenuated double auxotrophic 1leuD1panCD
strain of M. tuberculosis (Sampson et al., 2004, 2011) offers
significant advantages over M. smegmatis and BCG such as
similar genetic background, growth and antigenicity properties
to the widely used laboratory strain M. tuberculosis H37Rv.
For example, the growth rate of the 1leuD1panCD strain
in minimal medium supplemented with both leucine and
pantothenate was shown to be similar to that of wild-type
M. tuberculosis in minimal medium (Sampson et al., 2004).
Importantly, although the strain is fully attenuated, it was
shown to retain immunogenicity and protective capacity in
a sensitive guinea pig TB aerosol challenge model (Sampson
et al., 2004, 2011). In addition, the severely attenuated mutant
of M. tuberculosis has undergone rigorous in vitro and in vivo
safety testing, since it was originally developed as a TB vaccine
candidate (Sampson et al., 2004, 2011). The 1leuD1panCD
strain proved to be highly attenuated in the severe combined
immune deficient mouse M. tuberculosis model (Sampson et al.,
2004). The safety of this strain was further supported by evidence
that it does not cause disease in simian immunodeficiency
virus (SIV)-co-infected Rhesus macaques (Sampson et al.,
2011). Collectively this data indicates that in the case of
accidental infection with this strain in humans, it would be
highly unlikely to cause disease, even in immune-compromised
hosts. The 1leuD1panCD strain, therefore, holds minimal
risk to human health and environment and serves as an
excellent alternative model organism for TB research. Currently,
several international laboratories have been granted approval
to work with this and similar strains, under BSL2 conditions
(Movahedzadeh et al., 2008; Vilchèze et al., 2018).
We therefore aimed to compare M. tuberculosis H37Rv and
M. tuberculosis 1leuD1panCD to assess the suitability of this
auxotrophic strain as a model for M. tuberculosis research.
We provide comprehensive comparative analyses between
M. tuberculosis H37Rv and M. tuberculosis1leuD1panCD with
regards to in vitro and intra-macrophage growth, genomic
background, response to anti-TB agents, proteomic response to
stress, and the host immune response.
MATERIALS AND METHODS
Bacterial Strains and Culture
All bacterial strains utilized in this study are listed and described
in Table 1, along with relevant plasmid information. All
reagents were purchased from Sigma-Aldrich unless otherwise
specified. Liquid cultures of mycobacterial strains were grown in
Middlebrook 7H9 supplemented with 10% oleic acid-albumin-
dextrose-catalase (OADC, Becton Dickinson, NJ, United States),
0.2% (v/v) glycerol and 0.05% (v/v) Tween 80 (7H9-OGT),
with antibiotics as required for plasmid maintenance, at 37◦C,
with shaking at 180 rpm. M. tuberculosis1leuD1panCD liquid
cultures were additionally supplemented with 50 µg/ml leucine
and 24 µg/ml pantothenate. Electro-competent mycobacteria
were prepared and transformed as described by Snapper
et al. (1990). Solid media cultures of mycobacteria were
grown on 7H10 agar supplemented with 10% OADC, 0.5%
(v/v) glycerol and antibiotics at 37◦C and in the case of
M. tuberculosis1leuD1panCD, 50 µg/ml leucine and 24 µg/ml
pantothenate. Mycobacterial strains expressing the bacterial
luciferase operon from plasmid pMV306hsp + LuxCDABE
(Andreu et al., 2010) do not require an exogenous substrate
to produce light. Bioluminescence was used to measure the
intracellular growth of both the reference strain M. tuberculosis
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TABLE 1 | Plasmids and strains.
Plasmid/strain Description Source
pTiGc hsp60(ribo)-turboFP635 hsp60-gfp, KanR, episomal Mouton et al. (2016), Addgene plasmid 78314
pMV306hsp + LuxCDABE Bacterial luciferase operon, KanR, episomal Andreu et al. (2010), Addgene plasmid number 26519
M. smegmatis mc2155 Non-pathogenic, fast-growing model organism ATCC 700084
M. tuberculosis1leuD1panCD Double leucine and pantothenate auxotroph Sampson et al. (2004), gift from Prof. Bill Jacobs
M. tuberculosis H37Rv M. tuberculosis reference strain Gift from Prof. Barry Bloom
ATCC, American Type Culture Collection; HygR, hygromycin resistant; KanR, kanamycin resistant.
H37Rv and M. tuberculosis1leuD1panCD. The number of
generations were calculated based on either OD, luminescence
or median fluorescence intensity as previously described
(Mouton et al., 2016).
For proteomic analysis, M. tuberculosis H37Rv and
M. tuberculosis1leuD1panCD were cultured, separately, in
Middlebrook 7H9 broth supplemented with dextrose-catalase
(DC), 0.2% (v/v) glycerol and 0.05% (v/v) Tween 80 (7H9-
DC) at 37◦C. Mycobacterial cells were harvested (4000 rpm,
10 min, 4◦C) at an OD600 of ∼0.8, and the cells were washed
twice with ice-cold phosphate-buffered saline (PBS) pH 7.4.
Cells were washed with PBS to remove residual media before
LC-MS/MS analyses. Cells were either stored at −20◦C until
further processing (control), or resuspended in 7H9-DC (pH
4.5) and incubated for 48 h at 37◦C. Acid-stressed cultures were
subsequently washed twice by centrifugation at 4000 rpm for
10 min at 4◦C with ice-cold PBS pH7.4, and the pellets were
stored at−20◦C.
For testing the effect of acid stress on bacterial replication
using a dual-fluorescent replication reporter previously
developed by our group (Mouton et al., 2016), bacteria
were grown in 7H9-DC containing 4 mM Theophylline, to
induce the expression of TurboFP635, for 7 days until an OD600
of∼0.8 before washing with PBS. The cultures were sub-cultured
in 7H9-DC without Theophylline at pH 6.5 and pH 4.5 and
incubated for 48 h at 37◦C.
Genomic DNA Extraction
Genomic DNA was extracted by pelleting 15 ml culture at OD600
of 0.8 for 10 min at 4000 rpm and proceeding according to
previously published methods (Somerville et al., 2005).
Whole Genome Sequencing (WGS)
Whole genome sequencing was done on an Illumina NextSeq
550 instrument (Illumina, CA, United States) using a paired-
end approach with ∼600 base fragment sizes. One microgram
of DNA was used to prepare libraries for sequencing per the
manufacturer’s instructions using the NEBNext Ultra DNA
library preparation kit for Illumina (New England Biolabs,
MA, United States).
WGS Data Analyses
The Illumina paired-end reads for all isolates were
analyzed with open source software as described previously
(Black et al., 2015; Dippenaar et al., 2015). Identified
variants were compared between M. tuberculosis H37Rv
and M. tuberculosis1leuD1panCD. Deleted regions in
the genomes with respect to the M. tuberculosis H37Rv
NC000962.3 reference genome were detected with DELLY
and alignments of these regions were visually inspected
(Rausch et al., 2012).
MIC Determination Using BACTEC MGIT
960
Minimum inhibitory concentration (MIC) determinations were
performed using the semi-automated liquid culture BACTEC
MGIT 960 system (Becton Dickinson) and EpiCenter software
equipped with a TB eXist module for drug susceptibility
testing (DST) (Springer et al., 2009). Briefly, a bacterial
suspension was prepared from MGIT subcultures according
to the manufacturer’s instructions (BACTECTM MGITTM 960
System User’s Manual: Becton Dickinson Document Number
MA-0117) and 0.5 ml of the suspension was added to each
MGIT tube supplemented with 0.8 ml of OADC and 0.1 ml
of the drug (dissolved in DMSO) at a concentration range of
0.06–9.0 µg/ml for rifampicin or 0.0015–2.0 µg/ml for isoniazid.
M. tuberculosis1leuD1panCD was supplemented with 50 µg/ml
leucine and 24 µg/ml pantothenate. The MIC was determined as
the lowest drug concentration that tested susceptible (less than
100 growth units by automated reading when the control vial
turned positive).
Mammalian Cell Culture
RAW264.7 cells (ATCC TIB-71) were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM), supplemented with 10%
heat-inactivated fetal bovine serum (FBS) at 37◦C in 5% CO2.
Cells were passaged every 2–4 days. For infections, cells were
seeded at 5 × 104 cells per well in 96 well white plates.
M. tuberculosis H37Rv and M. tuberculosis1leuD1panCD were
prepared and infected into RAW264.7 macrophages as described
before (Mouton et al., 2016). Bacteria were added to macrophages
at a 10:1 ratio, and incubated at 37◦C in 5% CO2 for 3 h, prior
to penicillin/streptomycin treatment and subsequent washing, to
remove extracellular bacteria. Infected RAW264.7 macrophages
were cultured in the presence of DMEM, supplemented with
10% FBS, 50 µg/ml leucine and 24 µg/ml pantothenate to allow
growth of the auxotrophic strain inside macrophages. To assess
the uptake of bacteria by macrophages, cells were lysed with
sterile distilled water and pipetting, followed by colony forming
unit (CFU) determination by serial dilution plating of lysates
onto 7H10 agar, with leucine and pantothenate supplementation
where necessary. Macrophages infected with strains expressing
Frontiers in Microbiology | www.frontiersin.org 3 August 2019 | Volume 10 | Article 1922
fmicb-10-01922 August 17, 2019 Time: 15:44 # 4
Mouton et al. An Alternative Model for Tuberculosis Research
the bacterial luciferase operon were assessed for bioluminescence
expression using a microplate reader (POLARstar Omega, BMG
Labtech). Intracellular growth was monitored by measuring
bioluminescence every 24 h for 3 days. Macrophages infected
with mycobacteria that do not contain the luciferase operon
were included as controls to subtract background luminescence
expression from all samples.
Isolation and Infection of Peripheral
Blood Mononuclear Cells (PBMCs)
PBMCs were isolated from whole blood, of healthy TST negative
donors (n = 12), using Ficoll-Paque PLUS (GE Healthcare
Life Sciences, MA, United States) density (D > 1.077 g/ml)
gradient centrifugation. Informed consent was obtained
from all the subjects and the study was approved by
the Ethical Review Committee of the Faculty of Health
Sciences at Stellenbosch University (N16/05/070). Cells were
cultured in Roswell Park Memorial Institute (RPMI) media,
supplemented with 10% FBS at a density of 5 × 105 cells
per well in 48-well plates (Greiner Bio-one, Kremsmünster,
Austria). PBMCs were then infected with M. tuberculosis
H37Rv or M. tuberculosis1leuD1panCD at an MOI of 10:1,
treated with penicillin/streptomycin, followed by washing as
described above, before adding fresh RPMI, containing 10%
FBS. Uninfected and Lipopolysaccharide- (LPS; 10 µg/ml)
stimulated cells were included as negative and positive controls,
respectively. Supernatants were collected 24 h post-infection
and stored at -80◦C until cytokine analysis. To assess uptake,
PBMCs were lysed with sterile distilled water and pipetting,
followed by serial dilution plating and CFU determination as
described above.
Quantification of Cytokine and
Chemokine Levels by Multiplex Bead
Array
A human ProcartaPlexTM Multiplex Immunoassay (Thermo
Fisher Scientific, MA, United States) was used to simultaneously
quantify the levels of the following analytes in the culture
supernatants: interleukin (IL)-1β, IL-12p70, granulocyte
monocyte stimulating factor (GM-CSF), growth-regulated
oncogene (GRO)α, interferon (IFN)γ, macrophage inflammatory
protein (MIP)-1α (CCL3), tumor necrosis factor (TNF)α,
RANTES, stromal cell-derived factor (SDF)-1α. The assays were
performed according to the manufacturer’s instructions and
samples were evaluated in triplicate. The cytokine concentrations
were measured on a Bio-Plex platform (Bio PlexTM, Bio-Rad
Laboratories, CA, United States). A standard curve ranging
from 227 to 8,979.52 pg/ml for IL-1β, 7.15–29,426.85 pg/ml for
IL12-p70, 13.69–51,379.68 pg/ml for GM-CSF, 1.93–9993 pg/ml
GROα, 11.67–49,632.42 pg/ml for IFNγ, 1.5–6755.47 pg/ml for
MIP-1α, 7.85–33,043.15 pg/ml for TNFα, 0.86–837.85 pg/ml for
RANTES and 10.85–34,295.44 pg/ml for SDF-1, was used in the
assay. Correlation coefficients (r2 > 0.9) for the standard curves
were determined from transformed mean fluorescent intensity
values for each cytokine. Bio-Plex Manager Software, version 6.1,
was used to determine the median fluorescent intensities.
Proteomic Sample Preparation and
LC-MS/MS Analysis
Mycobacterial cells from 25 ml culture (performed in four
independent replicates) were mechanically lysed and whole-cell
lysates were processed for LC-MS/MS analysis using a modified
version of the filter-aided sample preparation (FASP) approach
(Wis´niewski et al., 2009). A total of 1 µg peptide mixture from
each sample was analyzed, independently, on an Orbitrap Fusion
Tribrid mass spectrometer (Thermo Fisher Scientific, MA,
United States), connected to a Thermo Scientific UltiMate 3000
RSLCnano System (Thermo Fisher Scientific, MA, United States)
(Detailed information is provided in Supplementary Data
Sheet S1).
Flow Cytometry Sample Preparation,
Acquisition, and Analyses
Samples were sonicated, fixed in 4% formaldehyde for 30 min
and washed twice in PBS, containing 0.05% Tween as previously
described (Mouton et al., 2016). Samples not immediately
analyzed were then stored at 4◦C. Immediately prior to flow
cytometry analyses samples were pelleted, resuspended in PBS
and filtered. Samples were analyzed using a FACSJazz flow
cytometer (Beckton Dickinson) for GFP fluorescent intensity
using a 488 nm laser (530/40 filter) and TurboFP635 fluorescent
intensity using a 561 nm laser (610/20 filter). For each sample,
30,000 events were captured and flow cytometry data were
analyzed using FlowJo vX.0.07r2 software. The number of
generations were calculated based on fluorescence intensity data
as described before (Mouton et al., 2016). Generation times are
expressed as mean± SD.
Data Analysis
We used an exploratory data analysis approach for the multiplex
bead array assay. Details are indicated in Supplementary
Data Sheet S1. All tandem mass spectra were analyzed using
MaxQuant 1.5.5.1 (Cox and Mann, 2008), and searched against a
customized M. tuberculosis proteome database. Custom database
construction was performed as previously described (Heunis
et al., 2017) and are detailed in Supplementary Data Sheet S1.
Exploratory data analysis and visualization were performed in the
R statistical programming language1.
RESULTS
Next-Generation Sequencing Reveals
Sequence Conservation Between
M. tuberculosis1leuD1panCD and
M. tuberculosis H37Rv
Whole genome sequencing of M. tuberculosis1leuD1panCD
and M. tuberculosis H37Rv (the reference strain in use in
our laboratory) was used to confirm sequence conservation
outside of the leuD and panCD regions. When comparing
1https://www.r-project.org/
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M. tuberculosis1leuD1panCD to our laboratory reference
strain M. tuberculosis H37Rv, only one unique non-synonymous
variant (I131T A > G) was identified at position 392 in Rv2988
(leuC) in M. tuberculosis1leuD1panCD that was not found
in M. tuberculosis H37Rv. However, no peptide covering this
region was identified in either of the two strains. Importantly,
the leuC gene is located upstream of the leuD deletion and no
proteomic differences were observed in downstream proteins
in the attenuated and wild type strains, suggesting an absence
of polar effects on expression. In agreement with the findings
of Ioerger et al. (2010), our analysis identified 33 variants in
both the attenuated M. tuberculosis1leuD1panCD strain and
M. tuberculosis H37Rv laboratory strain with respect to the
reference strain M. tuberculosis H37Rv, NC000962.3 (Ioerger
et al., 2010). However, 32 of these variants were identical
between the attenuated M. tuberculosis1leuD1panCD and
the M. tuberculosis H37Rv laboratory strain (Supplementary
Table S1). Visual inspection of the alignment confirmed
the expected 1297 bp panCD locus deletion at position
4043882–4045179 (M. tuberculosis H37Rv gene Rv3602c
and Rv3601c) and the leuD deletion at position 3344036–
3344394 (M. tuberculosis H37Rv gene Rv2987C) in the
attenuated M. tuberculosis1leuD1panCD, with respect to
M. tuberculosis H37Rv, NC000962.3. At a genomic level,
M. tuberculosis1leuD1panCD is therefore highly similar to
M. tuberculosis H37Rv.
The in vitro and Intra-Macrophage
Growth of M. tuberculosis1leuD1panCD
and M. tuberculosis H37Rv Are
Comparable
To confirm that the growth rates of
M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv
were similar in vitro, samples were taken for OD measurements
at predetermined time points (Figure 1A). Strains containing
the pTiGc plasmid were included to determine whether
plasmid carriage affected bacterial growth. One-way
ANOVA with Tukey’s multiple comparisons test revealed
no differences in growth rates between these strains
(p > 0.05). To confirm the auxotrophic nature of the
M. tuberculosis1leuD1panCD strain (Sampson et al.,
2004), OD measurements taken from strains supplemented
exogenously with leucine and pantothenate showed normal
growth, whereas restricted growth was observed in the absence
of pantothenate (Figure 1B).
We next assessed replication of M. tuberculosis
during macrophage infection. RAW264.7 macrophages
were infected with M. tuberculosis1leuD1panCD and
M. tuberculosis H37Rv strains expressing the bacterial luciferase
operon. Bioluminescence measurements demonstrated no
difference in the growth of these strains, suggesting similar
intracellular replication of M. tuberculosis1leuD1panCD
and M. tuberculosis H37Rv (Figure 1C). Pearson correlation
tests revealed a statistically significantly positive correlation
between generations calculated using luminescence for
M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv
(r = 0.975, N = 4, p = 0.0250).
M. tuberculosis1leuD1panCD and
M. tuberculosis H37Rv Respond Similarly
to Anti-tuberculosis Agents
One important potential application of the attenuated
M. tuberculosis1leuD1panCD strain is to allow for anti-
mycobacterial compound screening. Phenotypic DST of
the two first-line anti-tuberculosis drugs with different
mechanisms of action, rifampicin and isoniazid, confirmed
similar MICs for M. tuberculosis1leuD1panCD and
M. tuberculosis H37Rv. Specifically, the MIC for isoniazid
was determined to be 0.06 µg/ml for both strains, and
the MIC for rifampicin was determined to be 0.25 µg/ml
FIGURE 1 | Comparable growth of M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv strains. (A) M. tuberculosis1leuD1panCD (gray solid line, closed
symbols), M. tuberculosis1leuD1panCD containing the dual reporter pTiGc (gray dotted line, open symbols), M. tuberculosis H37Rv (black solid line, closed
symbols) and M. tuberculosis H37Rv containing pTiGc (black dotted line, open symbols) growth was monitored by OD. One-way ANOVA with Tukey’s multiple
comparisons test indicated no significant difference (p > 0.05). (B) OD600-based M. tuberculosis1leuD1panCD growth with exogenous supplementation of leucine
and pantothenate (gray line, open symbols) and without pantothenate supplementation (black line, closed symbols). (C) RAW264.7 macrophages were infected with
M. tuberculosis1leuD1panCD + LuxCDABE (gray line, open symbols) or M. tuberculosis H37Rv + LuxCDABE (black line, closed symbols), and intracellular
mycobacterial replication was compared by monitoring bioluminescence. Data shown are depicted as mean ± SD of three technical replicates and are
representative of three independent biological replicates. Pearson correlation tests revealed a statistically significantly positive correlation between generations
calculated using luminescence for M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv (r = 0.975, N = 4, p = 0.0250).
Frontiers in Microbiology | www.frontiersin.org 5 August 2019 | Volume 10 | Article 1922
fmicb-10-01922 August 17, 2019 Time: 15:44 # 6
Mouton et al. An Alternative Model for Tuberculosis Research
FIGURE 2 | Quality control analysis of proteomics data reveals distinct clustering of M. tuberculosis H37Rv and M. tuberculosis1leuD1panCD protein intensities.
(A) Principle component analysis of z-scored MaxQuant LFQ intensities obtained from M. tuberculosis H37Rv (blue) and M. tuberculosis1leuD1panCD (red) during
control (pH 6.5; square) and acid stress conditions (pH 4.5; circle). (B) Correlogram of Pearson correlation coefficients from MaxQuant LFQ intensities obtained for
M. tuberculosis H37Rv and M. tuberculosis1leuD1panCD (SAMMtb) cultured at pH 6.5 and pH 4.5.
for M. tuberculosis1leuD1panCD and 0.5 µg/ml for
M. tuberculosis H37Rv.
Proteomic Analysis Reveals an
Increased Stress Response in
M. tuberculosis1leuD1panCD
We performed LC-MS/MS analysis on the proteomes of
M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv grown
in media at pH 6.5 and pH 4.5. In total, we identified
21,779 unique peptides that mapped to 2,329 proteins, which
contained ≥ 2 unique peptides at an empirical protein FDR of
<1% (Supplementary Tables S2, S3). The proteins identified
in this study covered 58.33% of the predicted M. tuberculosis
H37Rv proteome. Principle component analysis revealed distinct
clustering of replicates and experimental groups (Figure 2A). The
first principle component (Component 1) explained 25% of the
variance in the data, which has an association with acid stress. The
second principle component (Component 2) explained ∼19%
of the variance in the data and was associated with inherent
strain differences between M. tuberculosis 1leuD1panCD
and M. tuberculosis H37Rv. Additionally, Pearson correlation
coefficients were higher within biological replicates than between
groups (Figure 2B), indicating high reproducibility between
independent experiments. Hierarchical clustering revealed two
major clusters that separated acid stressed M. tuberculosis
1leuD1panCD and M. tuberculosis H37Rv from the strains
grown under control (pH 6.5) conditions. Sub-clusters separated
M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv. Taken
together this data indicates that exposure to acid stress induced
more variance in the data than the inherent strain differences
between M. tuberculosis1leuD1panCD and M. tuberculosis
H37Rv, with the strains having similar protein expression profiles
under the conditions tested. However, some proteome-level
differences were observed between the two strains grown under
control (pH 6.5) and acid stress (pH 4.5) conditions.
We performed pair-wise comparisons to identify differences
in relative protein abundances between M. tuberculosis H37Rv
and M. tuberculosis1leuD1panCD. Twenty differentially
regulated proteins, with a twofold change and adjusted
p < 0.05, were identified when both of these strains were
grown at pH 6.5 (Figure 3A and Supplementary Table
S4). We detected 28 proteins as differentially regulated in
M. tuberculosis1leuD1panCD during acid stress, compared
to M. tuberculosis H37Rv (Figure 3B and Supplementary
Table S5). Interestingly, we observed 8 proteins that were more
abundant in acid-stressed M. tuberculosis1leuD1panCD
cells that were also detected as more abundant in
M. tuberculosis1leuD1panCD grown under physiological
conditions, compared to M. tuberculosis H37Rv under the same
conditions (Figure 3C). These included proteins that play a
role in dormancy, oxidative and/or nitrosative stress (AhpC,
AhpD), pantothenate metabolism (CoaX, PanB, Rv3603c),
transcription (Rv2989), methyl transfer (Rv2003c) and lipid
catabolism (Rv2037c). This, in addition to increased abundance
of DevR in M. tuberculosis1leuD1panCD during growth at pH
6.5, may suggest that M. tuberculosis1leuD1panCD experiences
a more pronounced baseline stress response than M. tuberculosis
H37Rv, which could be exacerbated during exposure to stress
and could lead to reduced bacterial replication. To test this
hypothesis we exploited a previously described dual-fluorescent
replication reporter and flow cytometry to assess the effect of
stress on bacterial replication. In accordance with our proteomics
analyses, M. tuberculosis1leuD1panCD demonstrated a more
pronounced decrease in bacterial replication in response to acid
stress, compared to M. tuberculosis H37Rv after 48 h (Figure 4).
M. tuberculosis1leuD1panCD Induces
Similar or Higher PBMC Cytokine and
Chemokine Responses Compared to
H37Rv
The concentration of 9 immune markers including cytokines,
chemokines and growth factors were measured in the
culture supernatant of PBMCs 24 h after infection with
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FIGURE 3 | Proteomic comparison of M. tuberculosis H37Rv and
M. tuberculosis1leuD1panCD under physiological in vitro growth conditions
and in response to acid stress. Volcano plot showing protein expression
differences between M. tuberculosis H37Rv compared to
M. tuberculosis1leuD1panCD when grown at pH 6.5 (A) and pH 4.5 (B).
Blue corresponds to proteins with <-1 log2 fold differential expression and
adjusted p < 0.05. Red corresponds to proteins with > 1 log2 fold differential
expression and adjusted p < 0.05. (C) Heatmap of log2 fold changes of
proteins showing statistically significant regulation between M. tuberculosis
H37Rv and M. tuberculosis1leuD1panCD during growth at pH 6.5 and pH
4.5.
M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv.
No statistically significant differences were observed in
RANTES, GROα, SDF-1, and IL-1β concentrations between
M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv
(Figures 5A–D). Despite demonstrating similar trends,
M. tuberculosis1leuD1panCD did induce higher concentrations
of TNFα (p = 0.0010), GM-CSF (p = 0.009), MIP-1α (p = 0.0021),
IL-12p70 (p < 0.0001), and IFNγ (p < 0.0001) when compared
to M. tuberculosis H37Rv (Figures 5E–I). M. tuberculosis H37Rv
induced low concentrations of IL-12p70 and IFNγ. Interestingly,
M. tuberculosis1leuD1panCD induced higher concentrations of
these two cytokines (Figures 5H,I).
DISCUSSION
We report here the assessment of attenuated
M. tuberculosis1leuD1panCD as a suitable and safe model
organism for M. tuberculosis research, without the need for
BSL3 facilities. This strain was originally developed as a TB
vaccine candidate (Sampson et al., 2004, 2011) and deletions
in the leucine and pantothenate biosynthesis pathways render
it safe to work with under BSL2 conditions, since it does
not replicate in the absence of exogenous supplementation
with leucine and pantothenate. Importantly, we compared
M. tuberculosis1leuD1panCD to M. tuberculosis H37Rv with
regards to in vitro and intra-macrophage growth, response to
anti-tuberculosis (TB) agents, genetic background, proteomic
response to acid stress and host immune response. Our data
supports the suitability of the attenuated strain as a model
for TB research.
M. tuberculosis H37Rv and M. tuberculosis 1leuD1panCD
replicated at similar rates in vitro and in murine macrophages;
this replication was not influenced by carriage of an additional
plasmid. In addition, the auxotrophic nature of M. tuberculosis
1leuD1panCD allows for growth limitation, by removal of either
pantothenate (as shown here), or leucine, or both supplements
(Sampson et al., 2004). This could provide a useful and tractable
stress model as a complement to other commonly used dormancy
models (Wayne and Hayes, 1996; Betts et al., 2002; Voskuil
et al., 2003, 2004; Leistikow et al., 2010) for investigating latent
TB in vitro.
A major goal in the field of TB drug development is
shortening the course of therapy by identifying new drugs.
Being able to do so without the need for a BLS3 facility
would greatly decrease cost and increase accessibility to
perform drug testing and screening. As proof-of-concept, we
compared susceptibility to rifampicin and isoniazid, key first-
line TB drugs with different mechanisms of action. Our
study shows similar MICs of rifampicin and isoniazid for
M. tuberculosis 1leuD1panCD and M. tuberculosis H37Rv,
although a slightly increased sensitivity was observed for
rifampicin for M. tuberculosis 1leuD1panCD compared to
M. tuberculosis H37Rv. Differences in the observed rifampicin
sensitivity for M. tuberculosis1leuD1panCD could be attributed
to the MICs being determined using serial twofold dilutions
according to the 1% proportion method; the actual MIC
value may therefore be anywhere between the highest drug
concentration that allows growth and the last dilution inhibiting
growth. The MIC measured for H37Rv may therefore not be 2X
the MIC obtained for the attenuated auxotrophic strain, since
the precision of the method is considered to be approximately
1 twofold concentration. The observed difference in the MIC
for rifampicin between the two strains is therefore within the
expected variability of the assay (Kim, 2005; World Health
Organisation [WHO], 2018b). However, testing a wider range
of anti-TB agents with different mechanisms of action would
provide a more comprehensive overview of the inhibition
of both strains.
Comprehensive proteomic analysis demonstrated a high
level of similarity between M. tuberculosis1leuD1panCD
and M. tuberculosis H37Rv when grown under physiological
conditions in vitro. Only 20 differentially regulated proteins
were identified when M. tuberculosis1leuD1panCD and
M. tuberculosis H37Rv were grown at pH 6.5, of which
16 were more abundant and four were less abundant in
M. tuberculosis1leuD1panCD. As expected, PanC was absent
in M. tuberculosis1leuD1panCD, which corresponds with the
deletion of the panCD region from the attenuated M. tuberculosis
strain (Sampson et al., 2004, 2011).
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FIGURE 4 | Fluorescence dilution demonstrates reduced replication of M. tuberculosis1leuD1panCD under acid stress in comparison to M. tuberculosis H37Rv.
M. tuberculosis H37Rv and M. tuberculosis1leuD1panCD containing pTiGc was cultured in the presence of 4 mM theophylline (Theo), before removal of
theophylline and exposure to pH 4.5 and pH 6.5 for 48 h prior to analyses by flow cytometry. Flow cytometry histograms demonstrate increased TurboFP635
fluorescence intensity in acidic media (pH 4.5, red), compared to normal media (pH 6.5, green) in M. tuberculosis1leuD1panCD (A) after 48 h. In contrast,
M. tuberculosis H37Rv demonstrated similar, reduced, TurboFP635 fluorescence intensity after 48 h in acidic media (pH 4.5, red) and control media (pH 6.5, green)
(B). Representative examples of three independent biological repeats are shown.
Potentially also linked to the panCD deletion, we
observed an increase in relative abundance of a type III
pantothenate kinase (CoaX) and a 3-methyl-2-oxobutanoate
hydroxymethyltransferase (PanB) that play a role in
pantothenate metabolism. PanB upregulation is likely as
a result of altered pantothenate metabolism introduced
during construction of the M. tuberculosis1leuD1panCD
strain. Supplementation with pantothenate in the culture
medium rescues the growth defect incurred by deletion of
panCD (as previously shown). Pantothenate is phosphorylated
during Coenzyme A (CoA) biosynthesis, and CoaX could
contribute to the phosphorylation of supplemented pantothenate
(Awasthy et al., 2010).
An alkyl hydroperoxide reductase C, AhpC, and an alkyl
hydroperoxide reductase, AhpD, were more abundant in
M. tuberculosis1leuD1panCD during growth at pH6.5. AhpD
reduces the active site cysteines in AhpC, an NADH-dependent
thiol peroxidase, required for the detoxification of peroxides
(Hillas et al., 2000; Bryk et al., 2002). Furthermore, a conserved
protein (Rv1531) predicted to have peroxiredoxin activity was
also more abundant in M. tuberculosis 1leuD1panCD. This
indicates that M. tuberculosis 1leuD1panCD may experience
increased oxidative and/or nitrosative stress during growth under
physiological conditions, as compared to M. tuberculosis H37Rv.
The transcriptional regulatory protein DevR/DosR was also more
abundant in this strain, further supporting a stress response in
M. tuberculosis 1leuD1panCD (Supplementary Figure S1). To
assess the possibility that the increased DevR/DosR abundance
could be caused by excess clumping of the attenuated strain,
we performed Ziehl-Neelsen staining of the 2 strains following
culture in the presence and absence of Tween 80, as well
as at pH 4.5 or pH 6.5 (Supplementary Figure S2). This
demonstrated no difference in clumping of the attenuated
auxotrophic strain compared to the M. tuberculosis H37Rv
strain in any of these conditions, indicating that clumping
did not influence the DevR/DosR abundance. DevR/DosR is
involved in initiating the dormancy response in mycobacteria
during exposure to a number of stresses (Sherman et al.,
2001; Boon and Dick, 2002; Park et al., 2003; Karakousis
et al., 2004; Sharma et al., 2006; Fontán et al., 2008; Kumar,
2008). Taken together, these results indicate that the proteomic
profile of M. tuberculosis1leuD1panCD in normal in vitro
culture conditions largely recapitulates that of M. tuberculosis
H37Rv. However, the attenuated strain may be skewed toward
a stress response, which should be taken into account during
experimental design.
We further probed the stress response of the
attenuated strain by comparing proteomic profiles of
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FIGURE 5 | Cytokine secretion in response to M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv. Cytokine release was assessed by Luminex analyses of
supernatants from PBMCs. Cells were seeded at 5 × 105 cells per well in a 48 well plate and infected with M. tuberculosis1leuD1panCD and M. tuberculosis
H37Rv (MOI 10:1) for 24 h. (A) RANTES, (B) Groα, (C) SDF-1, (D) IL-1β, (E) TNFα, (F) GM-CSF, (G) MIP-1α, (H) IL12-p70, (I) IFNγ. Lipopolysaccharide (LPS,
10 µg/ml)-stimulated and uninfected cells were included as controls. Supernatants were analyzed by multiplex assays using the Bio-Plex platform. The
log-transformed data were analyzed using a one-way ANOVA with a Tukey Honest Significant Differences (HSD) post hoc test. A p < 0.05 was regarded as
significantly different. All experiments were performed in technical triplicates.
M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv
following exposure to acid stress. Here, 28 differentially regulated
proteins were identified when M. tuberculosis1leuD1panCD
and M. tuberculosis H37Rv were exposed to pH 4.5 for 48 h,
of which 24 were more abundant and four were less abundant
in M. tuberculosis1leuD1panCD. As expected, PanC was less
abundant in acid-stressed M. tuberculosis1leuD1panCD when
compared to acid-stressed M. tuberculosis H37Rv.
We observed several proteomic differences that indicate a
possible increased propensity of M. tuberculosis1leuD1panCD
to enter a heightened stress state over M. tuberculosis H37Rv.
A dormancy-associated translation inhibitor (DATIN, Rv0079)
that forms part of the DosR regulon was more abundant
in acid-stressed M. tuberculosis1leuD1panCD (Mishra, 2009;
Kumar et al., 2012). DATIN gene expression has previously
been shown to be upregulated in hypoxic conditions (Voskuil
et al., 2004) and to induce pro-inflammatory cytokine expression
via interaction with Toll-like receptor 2 (Kumar et al.,
2013). A universal stress protein Rv3134c, also a member of
the dormancy regulon, was more abundant in acid-stressed
M. tuberculosis1leuD1panCD. This gene is the first member
of the Rv3134c-devR-devS operon and has been shown to be
upregulated during exposure to carbon monoxide (Kumar et al.,
2008; Shiloh et al., 2008), nitric oxide (Voskuil et al., 2004) and
hypoxic conditions (Sherman et al., 2001). Another member
of the dormancy regulon, Rv1738, was also more abundant in
acid-stressed M. tuberculosis1leuD1panCD. The Rv1738 gene
has been shown to be upregulated during exposure to hypoxia
(Sherman et al., 2001), carbon monoxide (Kumar et al., 2008),
and nitric oxide (Shiloh et al., 2008).
LeuA is involved in leucine biosynthesis and
could reflect leucine starvation in the auxotrophic
M. tuberculosis1leuD1panCD strain under acidic conditions.
It is highly likely that leucine import could be affected under
acidic conditions, placing further stress (in addition to the
acidic stress) on M. tuberculosis1leuD1panCD. Collectively, our
proteomic results suggest that M. tuberculosis1leuD1panCD
may exhibit a heightened stress response with associated
metabolic changes. Specifically, exposure to an experimentally-
induced stress (48 h exposure to pH 4.5) exacerbated this
stress response in M. tuberculosis1leuD1panCD. The
M. tuberculosis1leuD1panCD strain can thus serve as an
ideal model to study stress responses in M. tuberculosis under
BSL2 conditions. Furthermore, exploiting a dual-fluorescent
replication reporter and flow cytometry we demonstrated
markedly slower M. tuberculosis1leuD1panCD replication in
response to acid stress after 48 h of exposure, compared to
M. tuberculosis H37Rv. It is thus tempting to speculate that the
M. tuberculosis 1leuD1panCD strain will enter a viable, but
non-replicating (“dormant” or “persister”) state more readily
than M. tuberculosis H37Rv when exposed to unfavorable
conditions. However, this hypothesis requires further validation.
Another important potential application of attenuated strains
is for immunological assays. Although BCG has been widely
used for this (Hasso-Agopsowicz et al., 2018; Whittaker
et al., 2018), it lacks the RD1 region and as a result it
does not secrete many immunogenic proteins. Often cytokine
production levels are a major concern with regards to host
cells infected by attenuated strains, since many of them
have essential immunogenic proteins missing. Here we show
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that cytokine and chemokine production by PBMCs from
individuals infected with M. tuberculosis 1leuD1panCD is not
restricted and that several key cytokines (RANTES, GROα,
SDF-1 and IL-1β) are produced at comparable levels by
PBMCs infected with M. tuberculosis 1leuD1panCD and
M. tuberculosis H37Rv. While the research question would
need to be considered, M. tuberculosis 1leuD1panCD would
in many instances be a good representative strain to use as
a BSL2-appropriate alternative to M. tuberculosis H37Rv for
immunological assays.
Interestingly, we observed a higher inflammatory phenotype
for PBMCs infected with the attenuated M. tuberculosis strain
in comparison to the laboratory strain, H37Rv. Specifically,
TNFα, GM-CSF, MIP-1α, IL-12p70, and IFNγ were produced
at higher levels by PBMCs infected with M. tuberculosis
1leuD1panCD than those infected with M. tuberculosis
H37Rv. IL-12 plays an important role in anti-tuberculosis cell-
mediated immunity, and in addition to IL-18 are regarded
as the primary inducers of IFNy production in inflammatory
reactions (Trinchieri and Gerosa, 1996; Cooper et al., 1997;
Dinarello et al., 1998). Several M. tuberculosis strains from
different genetic backgrounds have demonstrated differences
in the inflammatory response they elicit (Wang et al.,
2010; Portevin et al., 2011; van Laarhoven et al., 2013).
More specifically, the response of human macrophages to
evolutionarily modern strains (bearing the TbD1 deletion,
such as Euro-American and Beijing strains) showed a lower
cytokine and chemokine production compared to ancestral
strains (Portevin et al., 2011). Also, macrophages infected
with non-Beijing strains such as Haarlem and LAM, showed
heterogeneous cytokine and chemokine production compared
to the Beijing strains that tend to induce homogeneously low
cytokine and chemokine production. A more recent study
has specifically shown that modern Beijing strains show less
induction of IL-1ß, IFNγ, and IL-22 in vitro, compared to ancient
Beijing and Euro-American reactivation strains (van Laarhoven
et al., 2013). Despite the highly similar genetic background,
the attenuated M. tuberculosis 1leuD1panCD strain elicited
higher production of analyzed cytokines, akin to the more
“ancient” M. tuberculosis lineages. Our proteomic analysis
indicated increased production of DATIN in acid-stressed
M. tuberculosis1leuD1panCD, which has previously been
implicated in increased proinflammatory cytokine expression
(Kumar et al., 2013). It is therefore tempting to speculate that
this may contribute to increased inflammatory responses, but this
remains to be experimentally determined.
CONCLUSION
We provide comprehensive evidence to support the judicious
application of M. tuberculosis 1leuD1panCD as a model
organism for TB research. The strain recapitulates many
characteristics of non-attenuated M. tuberculosis H37Rv, and
is especially suitable for researchers interested in working with
M. tuberculosis where access to BSL3 facilities is restricted
or unavailable, or where specific instrumentation may not be
available in a BSL3 setting. M. tuberculosis 1leuD1panCD may
find application in growth-based assays, drug testing, studies
of dormancy/persistence, omics analysis (transcriptomics,
proteomics and lipidomics), depending on research needs.
As with all other models, its suitability should be carefully
considered in the context of the research question. However,
findings reported here can assist researchers with making
an informed choice when using model organisms for
tuberculosis research.
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FIGURE S1 | Log2 LFQ intensities of DevR in M. tuberculosis1leuD1panCD and
M. tuberculosis H37Rv during acid stress. No difference in DevR expression was
observed between the two strains in acidic conditions (corrected p-value of 0.06),
based on a Benjamin–Hochberg correction for multiple hypothesis testing.
Differences in DevR expression levels are observed between
M. tuberculosis1leuD1panCD and M. tuberculosis H37Rv during acid stress,
when analyzing protein LFQ intensities without correction for multiple
hypothesis testing.
FIGURE S2 | Ziehl-Neelsen staining demonstrated no difference in clumping of
the attenuated auxotrophic strain compared to the M. tuberculosis H37Rv strain in
the presence and absence of Tween 80 in media with pH 4.5 or pH 6.5.
TABLE S1 | Unique and overlapping variants between M. tuberculosis H37Rv and
M. tuberculosis1leuD1panCD.
TABLE S2 | All peptides identified in this study.
TABLE S3 | All protein groups identified in this study.
TABLE S4 | Regulated protein groups in M. tuberculosis1leuD1panCD versus
M. tuberculosis H37Rv during 2 days exposure to 7H9 at pH 6.5.
TABLE S5 | Regulated protein groups in M. tuberculosis1leuD1panCD versus
M. tuberculosis H37Rv during growth in 7H9 at pH 4.5.
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